Stockscreener 앱 받기
226.93
0.30%
-0.68
전일 마감가:
$227.61
열려 있는:
$226.37
하루 거래량:
1.39M
Relative Volume:
3.74
시가총액:
$5.02B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-8.3033
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
+1.41%
1개월 성능:
-6.35%
6개월 성능:
-33.36%
1년 성능:
-19.53%
1일 변동 폭
$221.54
$228.33
1주일 범위
$221.54
$233.28
52주 변동 폭
$215.38
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
226.93 | 6.09B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Protein Characterization and Identification Market Is Booming WorldwideBio-Rad Laboratories, Agilent Technologies - openPR.com
Electrophoresis Reagents Market Detailed in New Research ReportBio-Rad Laboratories, Thermo Fisher Scientific - openPR.com
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference | BIO Stock News - GuruFocus
Bio-Rad Opens Exclusive Investor Access: COO Jon DiVincenzo Headlines at Jefferies Healthcare Conference - Stock Titan
Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com
Cell Analysis Market Deep Research Report Highlights New DevelopmentsBD Biosciences, Bio-Rad - openPR.com
Hemoglobin A1c Testing Devices Market To Witness Substantial - openPR.com
Difficult-to-Express Proteins Market Expansion Driven - openPR.com
Salmonella Testings Market to Witness Stunning Growth with Thermo Fisher, Bio-Rad, Merck - openPR.com
Flow Cytometry Market Deep Research with Forecast By 2025-2032 | - openPR.com
Protein Assays Market Set to Witness Significant Growth - openPR.com
Enzyme Linked Immunosorbent Assay Market Survey Detailed - openPR.com
Global Clinical Microbiology Market Trends, Growth & Analysis - openPR.com
Medical Biosensors Market 2025 | Latest Trends, Growth Forecast - openPR.com
Bio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growth - Investing.com Canada
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges - Investing.com Australia
Bio-Rad at RBC Healthcare Conference: Strategic Focus Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 01 - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Stock Price Down 4.42% on May 21 - GuruFocus
Polymerase Chain Reaction Market Deep Research Report with - openPR.com
Multiplex assays Market Set to Witness Significant Growth - openPR.com
Protein Chip Industry Forecast: Clean Ingredients, - openPR.com
Bio-rad outlines updated 2025 guidance amid academic and macro challenges - MSN
Antibody and Protein Labeling Kits Market Outlook, Trends, Growth and Opportunities | Exactitude Consultancy - GlobeNewswire Inc.
Karyotype Market Size, Growth Analysis 2031 by Key Vendors- - openPR.com
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket - MSN
Cytogenetic Systems Market Accelerates Owing to Increased - openPR.com
RNA Analysis Transcriptomics Market Top PlayersAgilent - openPR.com
Polyclonal Antibody Market Growth, Trends & Forecast 2025-2033 - openPR.com
Syphilis Immunoassay Diagnostics Market Detailed in New - openPR.com
Serum Market Is Booming Worldwide 2025-2032 | Thermo Fisher - openPR.com
Multiplex Assays Market Is Booming Worldwide 2025-2032 | Bio-Rad Laboratories, Inc.,Thermo Fisher Scientific - openPR.com
Microplate Systems Market Experiencing Steady Growth - openPR.com
Vector Purification Market 2025: Growth, Applications, - openPR.com
Enzyme Linked Immunosorbent Assay Market Set to Witness - openPR.com
Digital PCR Market in Research By 2031 | Most Leading Companies - openPR.com
Onco-hematology Molecular Testing Market Top Players - openPR.com
Protein Engineering Market Detailed In New Research Report 2025 - openPR.com
Transfection Technologies Market Competitive Growth - openPR.com
Research Antibodies Market Is Booming So Rapidly 2025-2032 - openPR.com
Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends - Yahoo
Electrophoresis Reagents Market: Trends, Drivers, - openPR.com
Bio-Rad's Management to Participate in Fireside Chat During 2025 - GuruFocus
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference - Business Wire
Bio-Rad Laboratories – Vericheck ddPCR™ Empty-Full Capsid Kit - Labmate Online
Hemoglobinopathy Market Set to Witness Significant Growth - openPR.com
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.38%
자본화:
|
볼륨(24시간):